SintilimabStevens-Johnson syndrome and toxic epidermal necrolysis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1927卷 / 1期

关键词：

D O I：

10.1007/s40278-022-25214-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：478 / 478

相关论文

共 50 条

[1] SintilimabStevens-Johnson syndrome: case report
[J]. Reactions Weekly, 2023, 1981 (1) : 333 - 333
[2] ItraconazoleStevens Johnson syndrome and toxic epidermal necrolysis: case report
[J]. Reactions Weekly, 2020, 1826 (1) : 189 - 189
[3] EculizumabSteven Johnson syndrome/toxic epidermal necrolysis: case report
[J]. Reactions Weekly, 2021, 1841 (1) : 102 - 102
[4] NorfloxacinStevens Johnson syndrome and toxic epidermal necrolysis: case report
[J]. Reactions Weekly, 2014, 1511 (1) : 34 - 34
[5] AllopurinolStevens Johnson syndrome/toxic epidermal necrolysis: case report
[J]. Reactions Weekly, 2022, 1906 (1) : 31 - 31
[6] LamotrigineStevens Johnson syndrome and toxic epidermal necrolysis: case report
[J]. Reactions Weekly, 2022, 1894 (1) : 198 - 198
[7] AmoxicillinStevens Johnson syndrome and toxic epidermal necrolysis: case report
[J]. Reactions Weekly, 2020, 1813 (1) : 24 - 24
[8] CarbamazepineStevens Johnson syndrome and toxic epidermal necrolysis: case report
[J]. Reactions Weekly, 2023, 1968 (1) : 84 - 84
[9] LamotrigineSteven Johnson syndrome - toxic epidermal necrolysis: case report
[J]. Reactions Weekly, 2015, 1548 (1) : 150 - 150
[10] AllopurinolStevens Johnson syndrome/toxic epidermal necrolysis: case report
[J]. Reactions Weekly, 2019, 1777 (1) : 19 - 19

← 1 2 3 4 5 →